From April 1, 2022 to June 30, 2022, the company has repurchased 1,444,464 shares, representing 0.09% for CNY 12.56 million. With this, the company has completed the repurchase of 2,194,806 shares, representing 0.13% for CNY 20 million under the buyback announced on February 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.14 CNY | -0.29% | -1.84% | -0.78% |
04-25 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-28 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.78% | 2.34B | |
-2.99% | 89.49B | |
+2.50% | 40.67B | |
-12.01% | 33.15B | |
+63.05% | 26.45B | |
-19.79% | 14.69B | |
-8.58% | 12.89B | |
-12.34% | 11.54B | |
-43.92% | 11.34B | |
+3.90% | 8.84B |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.